These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1139588)

  • 1. [The HL-A system and diseases (author's transl)].
    Nyulassy S; Iványi P
    Cas Lek Cesk; 1975 Mar; 114(13):287-97. PubMed ID: 1139588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incidence of histocompatibility antigens (HL-A) in skin diseases].
    Günther W; Richter KV
    Dermatol Monatsschr; 1975 May; 161(5):402-5. PubMed ID: 1183669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dependence of lymphocytic antigen HL-A 12 expressivity on the presence of HL-A 2 (author's transl)].
    Májský A
    Cas Lek Cesk; 1975 Aug; 114(33):1019-20. PubMed ID: 1164719
    [No Abstract]   [Full Text] [Related]  

  • 4. [HLA and illness].
    Solheim BG; Thorsby E
    Tidsskr Nor Laegeforen; 1976 Nov; 96(32):1705-6. PubMed ID: 1086518
    [No Abstract]   [Full Text] [Related]  

  • 5. [Human leukocytic antigens (HL-A) and diseases].
    Tananov AT
    Probl Gematol Pereliv Krovi; 1978 Mar; 23(3):45-50. PubMed ID: 77014
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA antigen associated immuneresponsiveness to insulin in insulin dependent diabetes mellitus [proceedings].
    Bertrams J; Jansen FK; Grüneklee D; Reis HE; Drost H; Beyer J; Gries FA; Kuwert E
    Z Immunitatsforsch Immunobiol; 1976 Dec; 152(4):309-13. PubMed ID: 1007381
    [No Abstract]   [Full Text] [Related]  

  • 7. [The influence of anti HL-A antibodies upon the course and final result of gravidity (author's transl)].
    Buc M; Nyulassy S; Stefanovic J; Cernay J; Uhercik D
    Cesk Gynekol; 1975 Aug; 40(7):528-31. PubMed ID: 1175238
    [No Abstract]   [Full Text] [Related]  

  • 8. [The HL-A system. Role of genetic factors in skin diseases].
    Gliński W
    Przegl Dermatol; 1977; 64(4):397-408. PubMed ID: 897235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Altered cytotoxic lymphocyte reactivity the cause of different results in studies of the relationship between HLA-antigens and disease (author's transl)].
    Májský A
    Cas Lek Cesk; 1975 Dec; 114(49):1518-20. PubMed ID: 1203938
    [No Abstract]   [Full Text] [Related]  

  • 10. [HLA antigens and their significance in dermatology. An outline (author's transl)].
    Novotný F
    Cesk Dermatol; 1981 Dec; 56(6):407-12. PubMed ID: 7307105
    [No Abstract]   [Full Text] [Related]  

  • 11. HL-A in Graves' disease and in diabetes mellitus insulin-dependent.
    Seignalet J; Mirouze J; Jaffiol C; Selam JL; Lapinski H
    Tissue Antigens; 1975 Oct; 6(4):272-4. PubMed ID: 1242826
    [No Abstract]   [Full Text] [Related]  

  • 12. HL-A and disease associations--a survey.
    Svejgaard A; Platz P; Ryder LP; Nielsen LS; Thomsen M
    Transplant Rev; 1975; 22():3-43. PubMed ID: 46644
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunology and immunogenetics in metabolic diseases.
    Cheţa D
    Med Interne; 1985; 23(1):3-12. PubMed ID: 3887542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes and the HLA system: epidemiological, genetic and etiological implications].
    Cathelineau G; Seignalet J
    Journ Annu Diabetol Hotel Dieu; 1977; ():134-47. PubMed ID: 894858
    [No Abstract]   [Full Text] [Related]  

  • 15. [HLA and diabetes (review)].
    Nerup J
    Journ Annu Diabetol Hotel Dieu; 1977; ():95-108. PubMed ID: 894882
    [No Abstract]   [Full Text] [Related]  

  • 16. [HLA system in symptomatic hepatic porphyria (author's transl)].
    Cervinka J; Kaláb M; Kordac V
    Cas Lek Cesk; 1981 Nov; 120(46):1408-11. PubMed ID: 7317925
    [No Abstract]   [Full Text] [Related]  

  • 17. [HLA-B 27 (W 27) antigen and other immunological factors in anklyosing spondylarthritis (author's transl)].
    Libich M; Májský A; Bartsch D
    Cas Lek Cesk; 1975 Dec; 114(49):1521-3. PubMed ID: 1203939
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calculation of the chance of paternity exclusion for the HL-A system (author's transl)].
    Mayr WR; Pausch V
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):447-57. PubMed ID: 133546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calculation of the plausibility of paternity in the HL-A system (author's transl)].
    Mayr WR
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jul; 144(1):18-27. PubMed ID: 4283238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Editorial: HL-A and diseases].
    Dausset J
    Nouv Presse Med; 1974 Mar; 3(9):499-501. PubMed ID: 4822147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.